Omega Therapeutics Inc Net Asset Momentum
Omega Therapeutics Inc net asset momentum. Omega Therapeutics Inc (OMGA) recorded a net asset momentum of -45.3% as of December 2023, with net assets of $58.02 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore OMGA operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Omega Therapeutics Inc (2019–2023)
Net asset momentum of Omega Therapeutics Inc from 2019 to 2023. This chart tracks Omega Therapeutics Inc's year-over-year net asset growth across 5 annual reporting periods from 2019 to 2023. The most recent momentum reading is -45.3%, with net assets of $58.02 Million USD as of December 2023. See OMGA net assets for net asset value and shareholders' equity analysis.
Omega Therapeutics Inc Net Asset Momentum by Year (2019–2023)
Omega Therapeutics Inc net asset momentum by year from 2019 to 2023. The table below shows the complete annual net asset history for Omega Therapeutics Inc from 2019 to 2023, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Omega Therapeutics Inc stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2023 | $58.02 Million | $204.37 Million | $146.35 Million | ▼ -45.3% |
| 2022 | $105.97 Million | $146.00 Million | $40.03 Million | ▼ -47.2% |
| 2021 | $200.63 Million | $233.33 Million | $32.70 Million | ▲ +410.4% |
| 2020 | $-64.63 Million | $28.08 Million | $92.71 Million | ▼ -79.9% |
| 2019 | $-35.92 Million | $6.12 Million | $42.04 Million | — |